Aysen Unsal is a Commercialisation Officer at Imperial College London
Technology Sectors & Industries
Therapeutics
Filter
LhARA: A radiobiological cancer therapy
LhARA is a Laser hybrid Accelerator for Radiobiological Applications in which laser interactions drive the creation of a large flux of protons or light ions.
Professor Kenneth Long
Long-lasting nanoparticles for controlled release drug delivery
A nanoparticle drug platform that can deliver small molecule drugs over a sustained period in a stable, low-toxic manner.
Emeritus Professor Bob Brown
Dr Ester Reina-Torres
Dr Blerina Ahmetaj-Shala
Professor Darryl Overby
Cellular therapy for glaucoma
A cellular therapy to locally deliver nitric oxide (NO) to the conventional aqueous humour outflow pathway, thereby lowering eye pressure and preserving vision in glaucoma.
anti-TCRVbeta Chimeric Antigen Receptors (CARs)
anti-TCRVbeta Chimeric Antigen Receptors which can target pathological T cells in a highly selective manner, leaving >90% of the patient’s T cells and T cell-dependent immunity intact.
Sign up for updates
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.